Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer-Reference-Cited by-同舟云学术

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer

Published:2019-01-15 Issue:5 Volume:10 Page:561-572
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

D’Arcangelo Manolo¹,D’Incecco Armida²,Ligorio Claudia³,Damiani Stefania³,Puccetti Maurizio⁴,Bravaccini Sara⁵,Terracciano Luigi⁶,Bennati Chiara¹,Minuti Gabriele¹,Vecchiarelli Silvia¹,Landi Lorenza¹,Milesi Marina⁷,Meroni Alberto⁸,Ravaioli Sara⁵,Tumedei Maria Maddalena⁵,Incarbone Matteo⁸,Cappuzzo Federico¹

Affiliation:

1. AUSL della Romagna, Department of Oncology-Hematology, Ravenna, Italy

2. University Hospital of Siena, Medical Oncology and Immunotherapy, Center for Immuno-Oncology, Siena, Italy

3. University of Bologna, DIMES, Pathology, Bologna, Italy

4. AUSL della Romagna, Department of Pathology, Ravenna, Italy

5. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCSS, Bioscences Laboratory, Meldola, Italy

6. University Hospital Basel, Institute of Pathology, Basel, Switzerland

7. Clinica San Carlo, Service of Pathology, Paderno Dugnano, Italy

8. RCCS MultiMedica, Thoracic Surgery, Sesto S.G., Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory gene polymorphisms in non-small cell lung carcinoma susceptibility and survival;Heliyon;2024-06

2. Prognostic implication of PD-L1 in early-stage non-small cell lung cancer: a retrospective single-centre study;Swiss Medical Weekly;2023-09-01

3. Establishing a predictive model for tumor mutation burden status based on CT radiomics and clinical features of non-small cell lung cancer patients;Translational Lung Cancer Research;2023-04

4. Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review;Cancers;2022-04-13

5. Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience;Cancers;2021-10-09